Logo image of ALAGR.PA

AGROGENERATION (ALAGR.PA) Stock Fundamental Analysis

EPA:ALAGR - Euronext Paris - Matif - FR0010641449 - Common Stock - Currency: EUR

0.0732  +0 (+3.98%)

Fundamental Rating

1

Overall ALAGR gets a fundamental rating of 1 out of 10. We evaluated ALAGR against 56 industry peers in the Food Products industry. ALAGR may be in some trouble as it scores bad on both profitability and health. ALAGR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALAGR has reported negative net income.
In the past year ALAGR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALAGR reported negative net income in multiple years.
ALAGR had a positive operating cash flow in 4 of the past 5 years.
ALAGR.PA Yearly Net Income VS EBIT VS OCF VS FCFALAGR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

1.2 Ratios

The Return On Assets of ALAGR (-11.44%) is worse than 83.93% of its industry peers.
ALAGR has a worse Return On Equity (-31.17%) than 83.93% of its industry peers.
The Return On Invested Capital of ALAGR (1.99%) is worse than 73.21% of its industry peers.
Industry RankSector Rank
ROA -11.44%
ROE -31.17%
ROIC 1.99%
ROA(3y)-31.43%
ROA(5y)-26.1%
ROE(3y)-85.75%
ROE(5y)-69.89%
ROIC(3y)N/A
ROIC(5y)N/A
ALAGR.PA Yearly ROA, ROE, ROICALAGR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

ALAGR has a Operating Margin (3.31%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALAGR has declined.
ALAGR has a worse Gross Margin (22.23%) than 76.79% of its industry peers.
ALAGR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.31%
PM (TTM) N/A
GM 22.23%
OM growth 3Y-19.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.59%
GM growth 5Y43.69%
ALAGR.PA Yearly Profit, Operating, Gross MarginsALAGR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALAGR is destroying value.
Compared to 1 year ago, ALAGR has about the same amount of shares outstanding.
Compared to 5 years ago, ALAGR has more shares outstanding
Compared to 1 year ago, ALAGR has an improved debt to assets ratio.
ALAGR.PA Yearly Shares OutstandingALAGR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
ALAGR.PA Yearly Total Debt VS Total AssetsALAGR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ALAGR has an Altman-Z score of -7.37. This is a bad value and indicates that ALAGR is not financially healthy and even has some risk of bankruptcy.
ALAGR has a worse Altman-Z score (-7.37) than 89.29% of its industry peers.
The Debt to FCF ratio of ALAGR is 11.27, which is on the high side as it means it would take ALAGR, 11.27 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALAGR (11.27) is comparable to the rest of the industry.
ALAGR has a Debt/Equity ratio of 0.63. This is a neutral value indicating ALAGR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, ALAGR is in line with its industry, outperforming 51.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.27
Altman-Z -7.37
ROIC/WACC0.33
WACC5.97%
ALAGR.PA Yearly LT Debt VS Equity VS FCFALAGR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

ALAGR has a Current Ratio of 1.08. This is a normal value and indicates that ALAGR is financially healthy and should not expect problems in meeting its short term obligations.
ALAGR has a Current ratio of 1.08. This is in the lower half of the industry: ALAGR underperforms 71.43% of its industry peers.
ALAGR has a Quick Ratio of 1.08. This is a bad value and indicates that ALAGR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.19, ALAGR is doing worse than 94.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.19
ALAGR.PA Yearly Current Assets VS Current LiabilitesALAGR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.60% over the past year.
ALAGR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.58%.
The Revenue for ALAGR have been decreasing by -16.23% on average. This is quite bad
EPS 1Y (TTM)66.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.33%
Revenue 1Y (TTM)-12.58%
Revenue growth 3Y-24.4%
Revenue growth 5Y-16.23%
Sales Q2Q%-12.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALAGR.PA Yearly Revenue VS EstimatesALAGR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALAGR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALAGR.PA Price Earnings VS Forward Price EarningsALAGR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

73.21% of the companies in the same industry are more expensive than ALAGR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALAGR is valued a bit cheaper than 76.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.92
EV/EBITDA 6.49
ALAGR.PA Per share dataALAGR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALAGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGROGENERATION

EPA:ALAGR (6/13/2025, 7:00:00 PM)

0.0732

+0 (+3.98%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.22M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.02
P/FCF 10.92
P/OCF 7.72
P/B 1.37
P/tB 1.37
EV/EBITDA 6.49
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY9.16%
OCF(TTM)0.01
OCFY12.96%
SpS0.07
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.44%
ROE -31.17%
ROCE 2.7%
ROIC 1.99%
ROICexc 2.11%
ROICexgc 2.12%
OM 3.31%
PM (TTM) N/A
GM 22.23%
FCFM 9.37%
ROA(3y)-31.43%
ROA(5y)-26.1%
ROE(3y)-85.75%
ROE(5y)-69.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-24.2%
ROICexcg growth 5YN/A
ROICexc growth 3Y-17.64%
ROICexc growth 5YN/A
OM growth 3Y-19.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.59%
GM growth 5Y43.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.27
Debt/EBITDA 1.57
Cap/Depr 14.44%
Cap/Sales 3.89%
Interest Coverage 6.24
Cash Conversion 43.83%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.19
Altman-Z -7.37
F-Score5
WACC5.97%
ROIC/WACC0.33
Cap/Depr(3y)25.01%
Cap/Depr(5y)21.52%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.58%
Revenue growth 3Y-24.4%
Revenue growth 5Y-16.23%
Sales Q2Q%-12.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2520%
EBIT growth 3Y-39.18%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.07%
OCF growth 3Y-65.36%
OCF growth 5Y-47.17%